Literature DB >> 18537784

Some main problems eroding the credibility and relevance of randomized trials.

John P A Ioannidis1.   

Abstract

Randomized trials are an excellent research design with major advantages. However, randomized trials are not immune to biases, and inferences from them may be sometimes flawed or irrelevant. The present review addresses, in brief, some of the major threats to the credibility and relevance of the results of clinical trials: power problems, biases affecting internal validity (poor design, conduct, and analysis), biases affecting the total randomized evidence on a specific topic (publication bias and selective outcome and analysis reporting bias), lack of relevance, poor generalizability, and biases in the interpretation of the results.

Mesh:

Year:  2008        PMID: 18537784

Source DB:  PubMed          Journal:  Bull NYU Hosp Jt Dis        ISSN: 1936-9719


  4 in total

Review 1.  Pharmacological treatment of bipolar depression: qualitative systematic review of double-blind randomized clinical trials.

Authors:  Lucas Spanemberg; Raffael Massuda; Lucas Lovato; Leonardo Paim; Edgar Arrua Vares; Neusa Sica da Rocha; Keila Maria Mendes Ceresér
Journal:  Psychiatr Q       Date:  2012-06

2.  Power(ful) myths: misconceptions regarding sample size in quality of life research.

Authors:  Samantha F Anderson
Journal:  Qual Life Res       Date:  2021-10-29       Impact factor: 3.440

3.  Hierarchies of evidence applied to lifestyle Medicine (HEALM): introduction of a strength-of-evidence approach based on a methodological systematic review.

Authors:  D L Katz; M C Karlsen; M Chung; M M Shams-White; L W Green; J Fielding; A Saito; W Willett
Journal:  BMC Med Res Methodol       Date:  2019-08-20       Impact factor: 4.615

4.  Workshop Report: concepts and methods in the economics of nutrition--gateways to better economic evaluation of nutrition interventions.

Authors:  I Lenoir-Wijnkoop; M J C Nuijten; I Gutiérrez-Ibarluzea; J Hutton; M J Poley; L Segal; J L Bresson; E van Ganse; P Jones; L Moreno; S Salminen; D Dubois
Journal:  Br J Nutr       Date:  2012-09-05       Impact factor: 3.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.